Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 28 5 2021
medline: 31 8 2021
entrez: 27 5 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

pubmed: 34039022
doi: 10.1161/ATVBAHA.120.315788
pmc: PMC8651054
mid: NIHMS1704179
doi:

Substances chimiques

APOL1 protein, human 0
Apolipoprotein L1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2201-2214

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL141425
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 DK043308
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 DK999999
Pays : United States

Références

Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
PLoS One. 2019 Apr 18;14(4):e0211559
pubmed: 30998685
J Am Coll Cardiol. 2021 Apr 6;77(13):1599-1611
pubmed: 33795033
J Am Soc Nephrol. 2019 Oct;30(10):2027-2036
pubmed: 31383730
J Am Soc Nephrol. 2011 Nov;22(11):2119-28
pubmed: 21997392
Circ Genom Precis Med. 2018 Jun;11(6):e002098
pubmed: 29899045
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403
pubmed: 26634651
J Am Soc Nephrol. 2020 Sep;31(9):2083-2096
pubmed: 32675303
J Am Soc Nephrol. 2016 Oct;27(10):3204-3219
pubmed: 27005919
Circulation. 2019 Sep 17;140(12):1031-1040
pubmed: 31337231
Kidney Int Rep. 2018 Oct 01;4(1):184-185
pubmed: 30596185
J Am Soc Nephrol. 2014 Mar;25(3):634-44
pubmed: 24231663
Science. 2010 Aug 13;329(5993):841-5
pubmed: 20647424
J Biol Chem. 1997 Oct 10;272(41):25576-82
pubmed: 9325276
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):55-63
pubmed: 24248942
Circulation. 1995 Aug 1;92(3):657-71
pubmed: 7634481
Kidney Int. 2015 Jan;87(1):169-75
pubmed: 25029429
Heart. 2000 Mar;83(3):361-6
pubmed: 10677422
Circulation. 2002 Jan 29;105(4):419-24
pubmed: 11815422
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Exp Mol Pathol. 2015 Jun;98(3):491-501
pubmed: 25796344
Circ Res. 2014 Feb 28;114(5):845-50
pubmed: 24379297
Kidney Int. 2015 Oct;88(4):754-63
pubmed: 25993319
J Cardiovasc Pharmacol. 2013 Sep;62(3):239-46
pubmed: 23743767
J Lipid Res. 2015 Aug;56(8):1583-93
pubmed: 26089538
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769
pubmed: 28572159
J Am Soc Nephrol. 2015 Nov;26(11):2882-90
pubmed: 25788523
J Am Soc Nephrol. 2002 Jun;13(6):1635-44
pubmed: 12039993
Kidney Int Rep. 2020 Mar 30;5(6):891-904
pubmed: 32518871
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
PLoS One. 2012;7(10):e48407
pubmed: 23110237
Kidney Int. 2011 Jun;79(12):1341-52
pubmed: 21307840
J Am Soc Nephrol. 2003 Nov;14(11):2902-7
pubmed: 14569100
Lancet. 2014 Aug 16;384(9943):618-625
pubmed: 25131981
Eur Heart J. 2013 Mar;34(10):719-28
pubmed: 23242196
Nat Med. 2017 Apr;23(4):429-438
pubmed: 28218918
Surgery. 1997 Oct;122(4):757-63; discussion 763-4
pubmed: 9347853
Cell Rep. 2020 Mar 17;30(11):3821-3836.e13
pubmed: 32187552
J Bras Nefrol. 2018 Oct-Dec;40(4):388-402
pubmed: 30052698
Autophagy. 2008 Nov;4(8):1079-82
pubmed: 18927493
Nephrol Dial Transplant. 2011 Nov;26(11):3805-10
pubmed: 21931123
Circulation. 2012 May 22;125(20):2469-78
pubmed: 22539783
N Engl J Med. 2013 Dec 5;369(23):2183-96
pubmed: 24206458
J Lipid Res. 2001 Apr;42(4):620-30
pubmed: 11290834
Cell. 2011 Apr 29;145(3):341-55
pubmed: 21529710
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):870-6
pubmed: 19325143
Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):153-5
pubmed: 19038847
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F326-36
pubmed: 24899058
Curr Opin Lipidol. 2017 Feb;28(1):39-45
pubmed: 27870653
J Lipid Res. 2000 Aug;41(8):1231-6
pubmed: 10946010
Biosci Rep. 2018 Aug 29;38(4):
pubmed: 29967295
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2894-9
pubmed: 25730870
J Am Soc Nephrol. 2019 Dec;30(12):2355-2368
pubmed: 31558683
N Engl J Med. 1997 May 1;336(18):1276-82
pubmed: 9113930
Annu Rev Physiol. 2020 Feb 10;82:323-342
pubmed: 31710572
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1282-92
pubmed: 20554950
Adv Anat Pathol. 2019 May;26(3):215-219
pubmed: 30624253
Kidney Int Rep. 2017 Jul;2(4):713-720
pubmed: 28758155
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3712-3721
pubmed: 30733285
Am J Cardiol. 2017 May 1;119(9):1313-1319
pubmed: 28279437
Kidney Int Rep. 2017 Aug 24;3(1):89-98
pubmed: 29340318
Kidney Int. 2015 Feb;87(2):332-42
pubmed: 25100047
J Am Soc Nephrol. 2011 Nov;22(11):2129-37
pubmed: 21997394
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):830-7
pubmed: 26699492

Auteurs

Anne Cornelissen (A)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).
Department of Cardiology, University Hospital RWTH Aachen, Germany (A.C.).

Daniela T Fuller (DT)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Raquel Fernandez (R)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Xiaoqing Zhao (X)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Robert Kutys (R)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Elizabeth Binns-Roemer (E)

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD (E.B.-R.).

Marco Delsante (M)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).
Dipartimento di Medicina e Chirurgia Università di Parma, UO Nefrologia, Azienda Ospedaliera-Universitaria, Italy (M.D.).

Atsushi Sakamoto (A)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Ka Hyun Paek (KH)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Rika Kawakami (R)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Masayuki Mori (M)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Kenji Kawai (K)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Teruhiko Yoshida (T)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).

Khun Zaw Latt (KZ)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).

Clint L Miller (CL)

Department of Public Health Sciences, Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville (C.L.M.).

Paul S de Vries (PS)

Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston (P.S.d.V.).

Frank D Kolodgie (FD)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Myung Kyun Shin (MK)

Merck & Co, Kenilworth, NJ (M.K.S., M.H.).

Maarten Hoek (M)

Merck & Co, Kenilworth, NJ (M.K.S., M.H.).

Jurgen Heymann (J)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).

Jeffrey B Kopp (JB)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).

Avi Z Rosenberg (AZ)

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (M.D., T.Y., K.Z.L., J.H., J.B.K., A.Z.R.).
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD (A.Z.R.).

Harry R Davis (HR)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Liang Guo (L)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).

Aloke V Finn (AV)

CVPath Institute, Gaithersburg, MD (A.C., D.T.F., R.F., X.Z., R. Kutys, A.S, K.H.P., Y.S., R. Kawakami, M.M., K.K., F.D.K., R.V., H.R.D., L.G., A.V.F.).
School of Medicine, University of Maryland School of Medicine, Baltimore (A.V.F.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH